x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments. For more information about GOA, visit www.globaloncologyacademy.org.

science & medicine medicine

All Episodes

00:00:00

Considerations for Dosing Bispecific Antibodies

Global Oncology Academy ·

2024/03/01

Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to

en

00:00:00

Preventing CRS and Neurotoxicities Related to...

Global Oncology Academy ·

2024/03/01

Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to

en

00:00:00

Bispecific Antibodies: The Newest Immunotherapy on...

Global Oncology Academy ·

2024/03/01

Host: Sagar Lonial, MD, FACP Guest: Caitlin Costello, MD "Bispecific Antibodies: A New Frontier in the Care of Patients With Refractory Multiple Myeloma” is a multiepisodic CME series exploring the role of bispecific antibodies for the treatment of heavily pretreated relapsed myeloma. Join our experts as they discuss the rationale for using these agents in the treatment of myeloma, strategies to monitor and manage treatment-related adverse events, and the pivotal data leading to

en

00:00:00

Balancing the Scales: The Complementary Roles of RCTs...

Global Oncology Academy ·

2023/12/08

Host: Christopher M. Gallagher, MDThis program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians’ confidence in their ability to discuss RWE with their patients.

en

00:00:00

Importance of the Patient Perspective on RWE in...

Global Oncology Academy ·

2023/12/08

Host: Adam Brufsky, MD, PhD Host: Christopher M. Gallagher, MD This program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians’ confidence in their ability to discuss RWE with their patients.

en

00:00:00

Unlocking Insights for Underrepresented Patients: The...

Global Oncology Academy ·

2023/12/08

Host: Adam Brufsky, MD, PhD This program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians’ confidence in their ability to discuss RWE with their patients.

en

00:00:00

RWE Supporting CDK4/6 Inhibitor Use in HR+ Metastatic...

Global Oncology Academy ·

2023/12/08

Host: Christopher M. Gallagher, MD This program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians’ confidence in their ability to discuss RWE with their patients.

en

00:00:00

Real World Use of RWE in HR+ Metastatic Breast...

Global Oncology Academy ·

2023/12/08

Host: Adam Brufsky, MD, PhD Host: Christopher M. Gallagher, MD This program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians’ confidence in their ability to discuss RWE with their patients.

en

00:00:00

Real World Evidence To Expand Knowledge of CDK4/6...

Global Oncology Academy ·

2023/12/08

Host: Christopher M. Gallagher, MD Host: Adam Brufsky, MD, PhD This program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians’ confidence in their ability to discuss RWE with their patients.

en

00:00:00

Distinguishing Between High- and Low-Quality RWE: A...

Global Oncology Academy ·

2023/12/08

Host: Adam Brufsky, MD, PhD This program focuses on increasing clinician familiarity and comfort with real-world evidence (RWE) of CDK4/6 inhibitors in metastatic breast cancer (MBC) and clinicians’ confidence in their ability to discuss RWE with their patients.

en

00:00:00

Revolutionary Approaches to Improving Outcomes in...

Global Oncology Academy ·

2023/11/15

Host: Ezra Cohen, MD Guest: Kevin J Harrington, PhD, FRCP, FRCR, FRSB Guest: Deborah J. Wong, MD, PhD Join our international multidisciplinary panel of experts in exploring revolutionary approaches to treating patients with unresectable locally advanced squamous cell carcinoma of the head and neck. The panel will address key aspects of patient management, including new and emerging therapies, the clinical significance of early endpoints used in clinical trials, and future

en

00:00:00

Keeping Pace in Hematologic Malignancies: 2023...

Global Oncology Academy ·

2023/07/24

Host: Harry Paul Erba, MD, PhD Guest: Courtney DiNardo, MD Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Immuno-oncologic agents have changed the treatment landscape for non-small cell lung cancer. Listen as Drs. Harry Erba and Courtney DiNardo discuss advances in molecular profiling and classification of AML, as well as the newest approved treatments.

en

00:00:00

Keeping Pace in Lung Cancer: Personalizing Treatment...

Global Oncology Academy ·

2023/04/17

Host: Mark Socinski, MD Guest: Patrick Forde, M.B.B.Ch. The optimal management of non-small cell lung cancer (NSCLC) has fundamentally changed. Targeted agents, mono and combination immunotherapy, and immunochemotherapy options continue to emerge. You also need to factor in new and investigational neoadjuvant and adjuvant regimens. So how do you determine which patients will benefit most within this new landscape of options? Join Drs. Mark Socinski and Patrick Forde as they address

en

00:00:00

Keeping Pace in Lung Cancer Personalizing Treatment...

Global Oncology Academy ·

2023/04/17

Host: Mark Socinski, MD Guest: Kristin Higgins, MD The clinical value of adding immunotherapy together with chemoradiation in locally advanced non-small cell lung cancer (NSCLC) has been evident since 2017. This concept has been extended through the emergence of key clinical trials, such as KEYNOTE-799, which includes both squamous and non-squamous subsets. In fact, the coalescence of chemoradiation and immunotherapy has begun to not only push up overall survival, but to also

en

00:00:00

Advancing Global Care with Emerging BTKi in...

Global Oncology Academy ·

2023/03/30

Host: Anthony Mato, MD, MSCE Guest: Toby A. Eyre, MD, MBChB Guest: Talha Munir, PhD The validation of targeted agent classes, driven by the emergence of BTK inhibitors as a highly effective therapeutic tool, has transformed the medical management of CLL/SLL and led to similar advances for other B-cell malignancies. Although this transformation has substantially improved outcomes, challenges remain and are centered on the problem of devising truly individualized sequential care

en

35 results

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe